Clinical trial
Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting…
NCT00430313 · M.D. Anderson Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00430313 |
|---|---|
| Title | Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin |
| Official title | Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Liver Cancer, Liver Metastasis |
| Intervention type | Procedure |
| Interventions | Electro-Stimulation of Yongquan (K1) Acupoint |
| Enrollment | 0 |
| Start date | Jan 4, 2007 |
| Primary completion | Aug 10, 2022 |
| Completion | Aug 10, 2022 |
| First posted | Feb 1, 2007 |
| Last update posted | Mar 29, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: